Pica Syndrome 1

Pick's disease is a type of neurodegenerative disease (dementia) that leads to progressive dementia. This syndrome was discovered in the 19th century by the Czech doctor Jiri-Pika (František Pick).

Peak syndrome appears in men at an average age of about 40-50 years, and in women a few years after that. After the peak of the process, in which a diagnosis can be made within the first year or two after the onset of symptoms, it worsens at an exponential rate. The disease has a genetic basis and is associated with gender. Pica syndrome is inherited in an X-linked manner and occurs in one in a thousand men in the world.

The syndrome begins with abnormal behavior by the patient, who often becomes more selfish and less sociable. Later symptoms include decreased memory and learning ability, confusion, and problems with speech and thinking. Cognitive difficulties progress over several years until the patient dies from non-dementia-related causes.

Treatment of Pick syndrome consists of symptomatic therapy and research work with the prospect of developing new treatment methods. There are currently several pharmaceutical drugs that may slow down the progression of the disease, but their effectiveness has not yet been proven. Efforts are also focused on developing more effective methods for early diagnosis and prognosis of a patient's condition.